Skip to Main Content

Author Details

Kateryna Krytska
University of Pennsylvania Perelman School of Medicine
2008
17
14
PMIDPaper TitleJournal TitlePublished Year
37012551Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.Nat Med2023
37147298Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma.Nat Commun2023
36381237Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma.Cancer Res Commun2022
34088831Venetoclax-based Rational Combinations are Effective in Models of <i>MYCN</i>-amplified Neuroblastoma.Mol Cancer Ther2021
33619171The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models.Clin Cancer Res2021
30563935Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models.Clin Cancer Res2019
31693904Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.Cell Rep2019
30867324An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma.Sci Transl Med2019
27986745Dual <i>ALK</i> and <i>CDK4/6</i> Inhibition Demonstrates Synergy against Neuroblastoma.Clin Cancer Res2017
26859456Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination.Cancer Cell2016
26438783Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.Clin Cancer Res2016
26554404The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma.Cancer Discov2016
25133137Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.Front Oncol2014
25517749ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.Cancer Cell2014
22592921Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.Am J Respir Cell Mol Biol2012
18315731Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice.Allergy2008
18554706Surfactant protein D inhibits TNF-alpha production by macrophages and dendritic cells in mice.J Allergy Clin Immunol2008
  • 1 - 17 of 17

Recommended Authors

German Cancer Research Center (DKFZ)
Career Start Year 2017
Number of shared co-authors 0
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2016
Number of shared co-authors 9
Children's Cancer Therapy Development Institute
Career Start Year 2011
Number of shared co-authors 2
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Laura and Isaac Perlmutter Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 0
University of Cologne, Faculty of Medicine and University Hospital Cologne
Career Start Year 2005
Number of shared co-authors 0
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 1
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2002
Number of shared co-authors 15
University of California san francisco
Career Start Year 2002
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 20
Peter MacCallum Cancer Centre
Career Start Year 2000
Number of shared co-authors 1
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1998
Number of shared co-authors 7
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 2
Oregon Health Sciences University
Career Start Year 1998
Number of shared co-authors 1
University of California san francisco
Career Start Year 1998
Number of shared co-authors 0
College of Human Medicine, Michigan State University
Career Start Year 1998
Number of shared co-authors 0
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 4
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 8
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 1
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1993
Number of shared co-authors 6
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 5
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1985
Number of shared co-authors 0
University of California san francisco
Career Start Year 1985
Number of shared co-authors 9
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 13
Children's Hospital of Philadelphia
Co-authored papers 6
Children's Hospital of Philadelphia.
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 3
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 3
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Cancer Center, Texas Tech University Health Sciences Center
Co-authored papers 3
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
Co-authored papers 2
Children's Hospital of Philadelphia
Co-authored papers 2
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Co-authored papers 2
Co-authored papers 2
Children's Hospital of Philadelphia
Co-authored papers 2
Children's Hospital Of Philadelphia
Co-authored papers 2
Virginia Commonwealth University
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 1
Co-authored papers 1
Wellcome Sanger Institute
Co-authored papers 1
University Hospital Regensburg
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Northwestern University
Co-authored papers 1
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 1
Massey Cancer Center
Co-authored papers 1
Greehey Children's Cancer Research Institute
Co-authored papers 1
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 1
Co-authored papers 1